Bone appearing on CT scans can be selectively removed with a mouse click, in this case, in front of the heart, using a new application built into the InSpace 4D program from Siemens Medical Solutions. The One Click Bone Removal application, which cleared the FDA in February, promises to make diagnosis of vascular problems easier. The application automatically segments and removes bony structures from CT angiograms. It can be set to show only bone, no bone, or soft and hard tissue. InSpace 4D is designed to assist physicians in the visualization and interactive review of large data sets commonly generated during multislice CT and MR exams. It can postprocess sets of up to 2000 images each in a 512-squared matrix of pixels. (Provided by Siemens Medical Solutions)
Bone appearing on CT scans can be selectively removed with a mouse click, in this case, in front of the heart, using a new application built into the InSpace 4D program from Siemens Medical Solutions. The One Click Bone Removal application, which cleared the FDA in February, promises to make diagnosis of vascular problems easier. The application automatically segments and removes bony structures from CT angiograms. It can be set to show only bone, no bone, or soft and hard tissue. InSpace 4D is designed to assist physicians in the visualization and interactive review of large data sets commonly generated during multislice CT and MR exams. It can postprocess sets of up to 2000 images each in a 512-squared matrix of pixels. (Provided by Siemens Medical Solutions)
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.